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Technical advances now allow catheter-based ﬁlter
retrieval. Many believe the beneﬁts of retrieval are self-
evident, yet retrieval carries an inherent complication risk
and cost. The purpose of this study was to quantitatively
weigh the risks and beneﬁts of IVC ﬁlter retrieval using
formal decision analysis.
Methods: A Markov state-transition model was used
to simulate two clinical scenarios: to leave a previously
placed IVC ﬁlter or to retrieve it. Analysis was performed
over the lifetime of the individual and outcomes were
expressed in quality-adjusted life-years (QALYs). The
base case is a 60-year-old man with a ﬁlter placed #3
months who no longer requires mechanical thrombopro-
phylaxis. Potential events included PE, ﬁlter complications,
and death from all other causes during each cycle. Tolls
were used to incorporate the disutility of short-term treat-
ment for PE and/or ﬁlter complications. For the base case
and sensitivity analyses, we used utilities and probabilities
derived from the literature.
Results: In the base-case scenario, leaving the ﬁlter in
place was preferred to ﬁlter retrieval, yielding 22.3 vs 21.9
QALYs. One-way sensitivity analysis demonstrated that ﬁl-
ter retrieval may be preferable if the utility of living with a
ﬁlter is <0.98. For all probabilities of retrieval and PE mor-
tality, leaving the ﬁlter in place is preferred.
Conclusions: Leaving a previously placed IVC ﬁlter
provides a 0.4 QALY beneﬁt over retrieving the ﬁlter for
the average patient. This decision is sensitive to the utility
of living with the IVC ﬁlter and underlying PE risk.
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Open Surgical Reconstruction for Benign Superior
Vena Cava Syndrome
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R. DeMartino, Ying Huang, Thomas C. Bower. Mayo
Clinic, Rochester, Minn
Objectives: To review long-term outcome of open
surgical reconstructions for benign superior vena cava
(SVC) syndrome.
Methods: The clinical data of all patients who under-
went open reconstruction for benign SVC syndrome be-
tween 1989 and 2012 were retrospectively reviewed.
Follow-up information was obtained from records, ques-
tionnaires, or phone calls.
Results: Forty-ﬁve patients, 29 females, 16 males
(mean age, 41 years; range 4-69 years) with symptomatic
SVC syndrome were included. Etiologies were central
catheters (n ¼ 20), ﬁbrosing mediastinitis (n ¼ 18), pace-
maker leads (n ¼ 2), and others (n ¼ 5). Percutaneous
recanalization was attempted in 14 patients, 10 underwent
previous stenting. Full sternotomy was done in 44 patients,
partial in one. The most common bypasses were left
innominate vein to right atrial bypass in 30 patients
(67%), and left innominate vein to SVC in eight (18%).Spiral vein graft was used in 21 patients (47%), expanded
polytetraﬂuoroethylene (PTFE) in 13 (29%), femoral vein
in 10 (22%), iliac vein homograft in 1 (2%). There was
no early mortality. Two patients (4%) required early reop-
eration due to graft obstruction, one required early endo-
vascular intervention. The mean follow-up was 6.2 6 5.8
years (range: 1 month-21 years). Late mortality occurred
in six patients (13%), all unrelated to the SVC reconstruc-
tion. Two patients required late reoperation for graft
obstruction. Late angioplasty with or without stenting
was required in 14 patients. One-year and 5-year primary
assisted patency rates were 96% and 86%, secondary
patency rates were 98% and 98%, respectively.
Conclusions: Benign SVC syndrome that is not suit-
able or that has failed endovascular treatment can be safely
and effectively treated by open surgical procedures, using
PTFE, femoral vein, or spiral vein grafts. Close surveillance
and secondary endovascular procedures help assure excel-
lent long-term durability.
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Cost Analysis of Negative Pressure Wound Therapy
with Instillation for Wound Bed Preparation
Preceding Split-Thickness Skin Grafts for Massive
(>100 cm2) Chronic Venous Leg Ulcers
Sean Alcantara, Selena Goss, Jamie Schwartz, Cynthia
Gendics, John Lantis. Vascular Surgery, St. Luke’s
Roosevelt Hospital, New York, NY
Objectives: The economic burden of venous leg ulcer-
ation (VLU) is well documented. Massive VLUs (>100
cm2) in particular demonstrate very low closure rates
with standard compression therapy. Split-thickness skin
grafts (STSG) can be used in conjunction with negative
pressure wound therapy (NPWT) as an alternative to stan-
dard of care. We performed a cost analysis of these two
treatments.
Methods: We looked at cost effectiveness of twice
weekly multilayer compression wraps compared with the
following protocol: (1) surgical debridement, (2) 7 days
of inpatient NPWT using a topical antiseptic (quarter
strength Dakin’s) instillation (NPWTi), and (3) STSG
with 4 days of inpatient NPWT bolster over the graft.
Cost was obtained through an independent, not-for-proﬁt
medical cost estimator, which estimated cost of a given
Current Procedural Terminology code adjusted for region.
Results: We estimated the cost of 6 months of twice-
weekly dressing changes to be $23,952, which included
costs of ofﬁce visits and dressing supplies. Cost of the pro-
posed treatment protocol was estimated to be $26,624,
which included an 11-day hospital stay and monthly
follow-up visits.
Conclusions: The protocol of debridement, NPWTi
using a topical antiseptic solution, and STSG with NPWT
bolster, has the potential to be economically advantageous
and a more effective alternative to standard compression
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strate improved wound closure rates in these large ulcers
with STSGs, the price difference becomes negligible and
may favor using an STSG.
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Compression Therapy Is Not Necessary After
Endovenous Ablation Therapy for the Treatment of
Varicose Veins
Angela Kokkosis, Harry Schanzer. Surgery, Mount Sinai
Medical Center, New York, NY
Objectives: Compression therapy is routinely used af-
ter endovenous saphenous ablation therapy (EVLT) for the
treatment of varicose veins. The rationale for compression
therapy is enhancement of vein closure and prevention of
superﬁcial thrombophlebitis (STP). A common patient
complaint postoperatively is the discomfort elicited by the
compression. The present work aims to determine whether
compression therapy is necessary as an adjunct to EVLT.
Methods: A total of 77 consecutive lower extremities
in 62 patients were treated with EVLT. Forty-two of the
treated extremities had postoperative compression, and
35 did not. All patients had duplex evaluation at 1 week af-
ter EVLT and then were clinically evaluated at 1 and 3
months. Primary end points were status of the treated
vein, presence or absence of STP, and the degree of vari-
cose vein resolution.
Results: There was no difference between compression
and no-compression groups in sex (63% vs 63% female), age
(59 vs 55 years), CEAP class (C2-C3, 81% vs 91%; C3-C4,
19% vs 9%), extent of varicose veins (<6 mm, 60% vs 66%;
>6 mm, 40% vs 34%), type of vein treated (great saphenous
vein, 80% vs 66%; small saphenous vein, 9% vs 20%; acces-
sory, 11% vs 14%) and operative variables. There was a
95% follow-up rate at 1 week, and all lower extremities
demonstrated saphenous vein closure. Three patients in
the compression group and no patients in the no-compres-
sion group had STP. No patients had deep venous throm-
bosis. At 1 month, both groups had the same rate of
varicose vein regression and need for secondary procedures.
Conclusions: Compression therapy does not add any
further beneﬁt to EVLT and therefore consideration
should be given to eliminating it, thus simplifying and
improving the postoperative recovery.
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Inferior Vena Cava Placement Utilization Among Over
250,000 Patients: National Trends, Complications,
and Relative Contraindications
Sapan S. Desai1, Anahita Dua2. 1Department of Surgery,
Duke University, Houston, Tex; 2Medical College of
Wisconsin, Milwaukee, WiscObjectives: The aim of this study was to evaluate
trends, complications, and risk factors that contribute to
morbidity associated with inferior vena cava (IVC) ﬁlter
placement.
Methods: A retrospective analysis of the National
Inpatient Sample (NIS), a 20% cross-section of all U.S.
inpatient admissions, was completed from 2000 to 2011
by identifying all patients who underwent IVC ﬁlter place-
ment (International Classiﬁcation of Diseases, Ninth Revi-
sion [ICD-9] 38.7). Complications including IVC
thrombosis (ICD-9 45.32) and death were determined.
Variables that were identiﬁed for each patient include
Agency for Healthcare Research and Quality (AHRQ)
standard comorbidities, clinical covariates including age,
gender, race, and insurance status. Propensity matching
was done to evaluate the effect of IVC ﬁlter placement
on reducing morbidity and mortality.
Results: A total of 251,295 patients (52% female)
were identiﬁed using the NIS, of which 2262 (0.9%) devel-
oped thrombosis of the IVC and 17,566 (7%) died. The
average age of admission was 66 years, 14% were elective
admissions. The rate of IVC thrombosis has decreased by
38% since 2000, paralleling the 50% decrease in mortality
over the same time period. Patients with comorbidities
including diabetes, hypertension, obesity, paralysis, chronic
obstructive pulmonary disease, renal failure, and heart dis-
ease were up to 2.3-times less likely to develop IVC throm-
bosis or die after receiving an IVC ﬁlter. Healthy men aged
<66 years were 2.2 times more likely to develop IVC
thrombosis after IVC ﬁlter placement. Overall, IVC ﬁlter
placement decreased morbidity from refractory deep vein
thrombosis and trauma by 30%.
Conclusions: IVC ﬁlter placement is effective in
reducing morbidity and mortality from deep vein throm-
bosis and trauma, particularly among patients aged >65
who have signiﬁcant comorbidities. However, IVC ﬁlter
placement among young, healthy men is disproportionately
associated with complications and its use should be re-eval-
uated among this population.
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Patients with Klippel-Trenaunay Syndrome
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Objectives: To assess safety and efﬁcacy of open surgi-
cal treatment (OST) vs endovenous radiofrequency abla-
tion (RFA) in patients with Klippel-Trenaunay syndrome
(KTS).
Methods: Clinical data of all patients with complex
mixed venous malformation treated for chronic venous
insufﬁciency from 2008 to 2013 were reviewed. Perioper-
ative complications and outcome after OST and RFA
were compared.
Results: Twenty-seven limbs of 26 patients (14 fe-
males; mean age, 33 years; range, 15-74) were treated.
All had varicose veins, 59% had limb overgrowth, and
63% had capillary malformations. Three had previous
